John Rim, Samsung Biologics CEO

Amidst large in­vest­ment from par­ent com­pa­ny, Sam­sung Bi­o­log­ics seeks to ramp up biotech fund­ing

Dur­ing End­points News’ time in San Diego for #BIO22, it was hard to miss all the Sam­sung Bi­o­log­ics signs plas­tered along­side the high­way to the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.